Loading…
Loading…
Customcells (CustomCells Itzehoe GmbH) is a German developer and manufacturer of custom lithium-ion battery cells and modules, founded in 2012 as a spin-off from the Fraunhofer Institute for Silicon Technology (ISIT) in Itzehoe, Schleswig-Holstein.
Privately held; no LEI record found (GLEIF search by legal name and by trading name both returned no match). Rescued from 2025 insolvency in July 2025 by a consortium led by existing investor Abacon, joined by two further capital providers including Salvia family office; no single controlling shareholder or stake percentage disclosed. Treated as privately/consortium-held, not a subsidiary -- no parent_slug set (no dossier exists for Abacon or Salvia, which are investment vehicles, not operating companies).
Another tracked dossier names this company as a counterparty in its own sourced disclosure — this platform never wrote these rows on this company's own page, they are read here inverted from the dossier that disclosed them. This is a partial view: 985 additional named-counterparty rows across the corpus could not be matched to a tracked dossier by name at all (mostly non-Latin legal names), so the true count is higher than what renders here.
Co-development partnership for two new cylindrical cell designs, announced mid-Jan 2025 (corroborated by electrive.com). Does not confirm incumbent cell supplier or cathode chemistry — see body note on why Co/Ni/Mn remain excluded from material_exposures.
Scope. This section is inverted evidence: each linked dossier wrote the original row about itself, describing its own relationship to this company. It is never a claim this company itself disclosed. Absence here is not evidence of no relationship — most of the corpus has no named-counterparty block at all yet.
Every exposure is read as a buyer dependency; the top 3 are its binding chokepoints.
As a buyer, policy pressure across its consumed materials is flat.
Descriptive trend in official policy actions on this company’s materials — a policy-pressure trend, not a price or trading signal. No forward probability is implied. Direction is measured on actions we have discovered, and discovery lags events: where the recent window is too thin to support a calm reading, the row says coverage-limited instead of easing.
No actions in the register have named or swept this company in the last 24 months.